Literature DB >> 16540665

The oncogenic epidermal growth factor receptor variant Xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions.

Svenja Meierjohann1, Elisabeth Wende, Anita Kraiss, Claudia Wellbrock, Manfred Schartl.   

Abstract

One of the most prominent features of malignant melanoma is the fast generation of metastasizing cells, resulting in the poor prognosis of patients with this tumor type. For this process, cells must gain the ability to migrate. The oncogenic receptor Xmrk (Xiphophorus melanoma receptor kinase) from the Xiphophorus melanoma system is a mutationally activated version of the epidermal growth factor receptor that induces the malignant transformation of pigment cells. Here, we show that the activation of Xmrk leads to a clear increase of pigment cell motility in a fyn-dependent manner. Stimulation of Xmrk induces its interaction with the focal adhesion kinase (FAK) and the interaction of active, receptor-bound fyn with FAK. This results in changes in FAK activity and induces the modulation of stress fibers and focal adhesions. Overexpression of dominant-negative FAK shows that the activity of innate FAK and a receptor-induced focal adhesion turnover are a prerequisite for pigment cell migration. Our findings show that in our system, Xmrk is sufficient for the induction of pigment cell motility and underlines a role of the src family protein tyrosine kinase fyn in melanoma development and progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540665     DOI: 10.1158/0008-5472.CAN-05-2667

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

2.  SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration.

Authors:  Weiwen Long; Ping Yi; Larbi Amazit; Heather L LaMarca; Felicity Ashcroft; Rakesh Kumar; Michael A Mancini; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

Review 3.  Genetic and environmental melanoma models in fish.

Authors:  E Elizabeth Patton; David L Mitchell; Rodney S Nairn
Journal:  Pigment Cell Melanoma Res       Date:  2010-03-08       Impact factor: 4.693

4.  Transcriptional control analyses of the Xiphophorus melanoma oncogene.

Authors:  Janine Regneri; Jean-Nicolas Volff; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-05       Impact factor: 3.228

5.  MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.

Authors:  Svenja Meierjohann; Anita Hufnagel; Elisabeth Wende; Markus A Kleinschmidt; Katarina Wolf; Peter Friedl; Stefan Gaubatz; Manfred Schartl
Journal:  Mol Cancer       Date:  2010-07-28       Impact factor: 27.401

6.  Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.

Authors:  Janka Teutschbein; Johannes M Haydn; Birgit Samans; Michael Krause; Martin Eilers; Manfred Schartl; Svenja Meierjohann
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

7.  NRF2 Enables EGFR Signaling in Melanoma Cells.

Authors:  Julia Katharina Charlotte Kreß; Christina Jessen; André Marquardt; Anita Hufnagel; Svenja Meierjohann
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

8.  Lineage-specific co-evolution of the Egf receptor/ligand signaling system.

Authors:  Juliette A G C Laisney; Ingo Braasch; Ronald B Walter; Svenja Meierjohann; Manfred Schartl
Journal:  BMC Evol Biol       Date:  2010-01-27       Impact factor: 3.260

Review 9.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

10.  The MAPK pathway as an apoptosis enhancer in melanoma.

Authors:  Johannes M Haydn; Anita Hufnagel; Johannes Grimm; Katja Maurus; Manfred Schartl; Svenja Meierjohann
Journal:  Oncotarget       Date:  2014-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.